首页> 外文期刊>Therapeutic advances in chronic disease. >Specific composition of polyphenolic compounds with fatty acids as an approach in helping to reduce spirochete burden in Lyme disease: in vivo and human observational study
【24h】

Specific composition of polyphenolic compounds with fatty acids as an approach in helping to reduce spirochete burden in Lyme disease: in vivo and human observational study

机译:用脂肪酸的多酚化合物的具体组合物作为帮助降低莱姆病的螺旋荷载荷的方法:体内和人类观察研究

获取原文

摘要

Background: Lyme disease (LD) is a tick-borne infection caused by Borrelia burgdorferi sensu lato. The current therapeutic approach to this disease is limited to antibiotics. However, after their administration, about 20% of patients experience delayed onset of this illness manifesting as lingering persistent symptoms. Methods: To determine a suitable approach that would help reduce this number, we examined the efficacy of a composition of polyphenolic compounds (baicalein, luteolin, and rosmarinic acid) with fatty acids (monolaurin and cis-2-decenoic acid), and iodine/kelp in a Lyme disease animal model and volunteers. Results: The results showed that 4?weeks of dietary intake of this composition reduced the spirochete burden in animal tissues by about 75%. Basic and differential blood parameters did not show significant differences between control animals and the animals fed with this composition. Also, hepatic and renal toxicity markers were not changed and apoptosis was not observed. Relevant inflammatory cytokines such as IL-6, IL-17, TNF-α, and INF-γ, were elevated in infected animals but normalized in infected and treated animals. A small observational study revealed that after administration of this composition to 17 volunteers three times per day for 6?months, 67.4% of the volunteers with late or persistent LD, and not receptive to previous antibiotic application, responded positively, in terms of energy status as well as physical and psychological wellbeing to supplementation with this composition, while 17.7% had slight improvement, and 17.7% were none responsive. Conclusion: We concluded that this specific composition revealed feasible benefits in late or persistent LD management, although double-blind controlled clinical trials are warranted.
机译:背景:莱姆病(LD)是由Borrelia Burgdorferi Sensu Lato引起的蜱传染。目前该疾病的治疗方法仅限于抗生素。然而,在他们的行政后,大约20%的患者经历这种疾病的延迟表现为挥之不去的持续症状。方法:确定有助于减少该数量的合适方法,我们检查了多酚化合物(Baicalin,菱形和玫瑰酰胺酸)与脂肪酸(单磺苷和顺式-2-癸烯酸)的疗效,以及碘/ Kelp在莱姆病动物模型和志愿者。结果:结果表明,该组合物的40周的膳食摄入量将动物组织的螺旋体减少约75%。基本和差异血液参数在对照动物和用该组合物喂养的动物之间没有显示出显着差异。此外,肝癌和肾毒性标记没有改变,未观察到细胞凋亡。在感染的动物中升高了相关的炎性细胞因子,例如IL-6,IL-17,TNF-α和INF-γ,但在感染和处理的动物中标准化。一个小的观察性研究表明,在每天3次施用该组合物至17次志愿者6?月份,67.4%的志愿者晚期或持久性LD,并且在能量状况方面,对​​先前的抗生素应用没有接受,响应了响应除了用这种组合物补充的身体和心理健康,而17.7%略有改善,17.7%无响应。结论:我们得出结论,这种特定的组成在晚期或持久的LD管理中揭示了可行的益处,尽管有保证双盲对照临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号